NO942899D0 - - Google Patents

Info

Publication number
NO942899D0
NO942899D0 NO942899A NO942899A NO942899D0 NO 942899 D0 NO942899 D0 NO 942899D0 NO 942899 A NO942899 A NO 942899A NO 942899 A NO942899 A NO 942899A NO 942899 D0 NO942899 D0 NO 942899D0
Authority
NO
Norway
Prior art keywords
stabilization
radiopharmaceutical
relates
present
components
Prior art date
Application number
NO942899A
Other languages
English (en)
Norwegian (no)
Other versions
NO942899L (no
Original Assignee
Mallinckrodt Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Medical Inc filed Critical Mallinckrodt Medical Inc
Publication of NO942899L publication Critical patent/NO942899L/no
Publication of NO942899D0 publication Critical patent/NO942899D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
NO942899A 1992-02-14 1994-08-04 Stabiliserte, radiofarmasöytiske sett NO942899L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/836,644 US5300280A (en) 1992-02-14 1992-02-14 Stabilized radiopharmaceutical kits
PCT/US1993/001196 WO1993015765A1 (fr) 1992-02-14 1993-02-09 Kits radiopharmaceutiques stabilises

Publications (2)

Publication Number Publication Date
NO942899L NO942899L (no) 1994-08-04
NO942899D0 true NO942899D0 (fr) 1994-08-04

Family

ID=25272404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942899A NO942899L (no) 1992-02-14 1994-08-04 Stabiliserte, radiofarmasöytiske sett

Country Status (15)

Country Link
US (2) US5300280A (fr)
EP (2) EP1690552A3 (fr)
JP (1) JPH07503960A (fr)
AT (1) ATE378073T1 (fr)
AU (1) AU3662493A (fr)
BG (1) BG98971A (fr)
CA (1) CA2129755C (fr)
DE (1) DE69334183T2 (fr)
FI (1) FI943724A (fr)
HU (1) HUT74566A (fr)
IL (1) IL104655A (fr)
NO (1) NO942899L (fr)
SK (1) SK96694A3 (fr)
WO (1) WO1993015765A1 (fr)
ZA (1) ZA93949B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5744120A (en) * 1993-03-30 1998-04-28 The Dupont Merick Pharmaceutical Company Ternary radiopharmaceutical complexes
CA2158249A1 (fr) * 1993-03-31 1994-10-13 James W. Brodack Formulations radiopharmaceutiques renfermant des reducteurs non stanneux
US5993777A (en) * 1993-05-06 1999-11-30 Research Corporation Technologies, Inc. Benzamide compounds for cancer imaging and therapy
US6517811B2 (en) 1993-05-06 2003-02-11 Research Corporation Technologies, Inc. Compounds for cancer imaging and therapy
US5911970A (en) * 1993-05-06 1999-06-15 Research Corporation Technologies, Inc. Methods for cancer imaging and therapy using benzamine compounds
US5951964A (en) * 1993-06-04 1999-09-14 Diatide, Inc. Technetium-99m labeled peptides for imaging
FR2726765B1 (fr) * 1994-11-14 1996-12-20 Cis Bio Int Compositions radiopharmaceutiques comprenant un complexe d'inclusion d'une cyclodextrine et d'un acide gras radiohalogene
US5762903A (en) * 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
WO1997039761A1 (fr) 1996-04-19 1997-10-30 Alpha Therapeutic Corporation Procede d'inactivation de virus dans des proteines sanguines lyophilisees
IT1289660B1 (it) * 1996-10-03 1998-10-16 Sorin Biomedica Diagnost Spa Procedimento per la riduzione di composti ossigenati del renio o del tecnezio
WO1998029139A1 (fr) * 1996-12-25 1998-07-09 Gosudarstvenny Nauchny Tsentr Fiziko-Energetichesky Institut PREPARATION CONTENANT UN COMPOSE ORGANIQUE MARQUE A L'AIDE D'UN RADIONUCLEIDE $g(b)
NZ507949A (en) * 1998-09-25 2002-03-01 Tokyo Gas Co Ltd C-13 or C-14 labelled fluorescein derivatives and diagnostic compositions
US6905668B1 (en) * 1998-09-25 2005-06-14 Tokyo Gas Company Limited Diagnostic agents for pancreatic exocrine function
US6056941A (en) * 1999-07-28 2000-05-02 Bracco Research Usa Kit for the preparation of technetium TC 99m teboroxime myocardial perfusion agent
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
US7229603B2 (en) * 2004-06-17 2007-06-12 Anazaohealth Corporation Stablilized and lyophilized radiopharmaceutical agents
WO2006085941A1 (fr) * 2004-06-17 2006-08-17 Anazaohealth Corporation Procédé et agent d’imagerie par tomographie à émission positronique (tep) d’isonitrile à complexe de cuivre
WO2006009894A1 (fr) * 2004-06-17 2006-01-26 Anazaohealth Corporation Agents radiopharmaceutiques stabilisés et lyophilisés pour détruire des tumeurs
GB0427392D0 (en) * 2004-12-15 2005-01-19 Amersham Plc Stabilised 99mTc compositions
US9321095B2 (en) 2010-06-30 2016-04-26 General Electric Company Apparatuses and methods for cutting porous substrates
GB201915206D0 (en) * 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219270A (ja) * 1983-05-30 1984-12-10 Wako Pure Chem Ind Ltd テトラゾリウム塩を含有する溶液の安定化方法
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPH064770B2 (ja) * 1984-07-31 1994-01-19 三菱電機株式会社 ジチオラト錯体−シクロデキストリン包接化合物の製造方法
IL76889A0 (en) * 1984-11-02 1986-02-28 Johnson Matthey Plc Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US4714605A (en) * 1986-10-14 1987-12-22 E. R. Squibb & Sons, Inc. Technetium-99m labeled dioxime complexes
US4871836A (en) * 1987-10-13 1989-10-03 E. R. Squibb & Sons, Inc. Boronic acid adducts of rhenium and radioactive isotopes of rhenium dioxime complexes
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
CA1321192C (fr) * 1988-04-20 1993-08-10 Abdul Majid Complexes d'inclusion de cyclodextrines obtenus par agglomeration
US5002754A (en) * 1988-06-15 1991-03-26 University Of Cincinnati Technetium (III/II) imaging agents
US5068227A (en) * 1989-01-18 1991-11-26 Cyclex, Inc. Cyclodextrins as carriers
US4917879A (en) * 1989-05-19 1990-04-17 University Of Cincinnati 99MTC(III) myocardial imaging agents that are effective in humans
US5080884A (en) * 1989-12-12 1992-01-14 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol radionuclide complexes and their use in imaging
US5026913A (en) * 1989-12-12 1991-06-25 Medi-Physics, Inc. Hydrocarbylphenyl diaminodithiol derivatives
US5183653A (en) * 1990-04-13 1993-02-02 E. R. Squibb & Sons, Inc. Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
US5112595A (en) * 1990-12-21 1992-05-12 Mallinckrodt Medical, Inc. 99MTC(III) myocardial imaging agents and method of use

Also Published As

Publication number Publication date
EP0625054B1 (fr) 2007-11-14
DE69334183D1 (de) 2007-12-27
FI943724A0 (fi) 1994-08-12
BG98971A (en) 1995-06-30
JPH07503960A (ja) 1995-04-27
FI943724A (fi) 1994-08-12
ATE378073T1 (de) 2007-11-15
US5300280A (en) 1994-04-05
EP1690552A2 (fr) 2006-08-16
SK96694A3 (en) 1995-03-08
EP1690552A3 (fr) 2008-07-02
CA2129755A1 (fr) 1993-08-15
US6428768B1 (en) 2002-08-06
WO1993015765A1 (fr) 1993-08-19
IL104655A0 (en) 1993-06-10
IL104655A (en) 1998-06-15
EP0625054A4 (en) 1996-04-17
HU9402349D0 (en) 1994-10-28
NO942899L (no) 1994-08-04
EP0625054A1 (fr) 1994-11-23
DE69334183T2 (de) 2008-11-06
ZA93949B (en) 1993-12-07
CA2129755C (fr) 2006-01-03
AU3662493A (en) 1993-09-03
HUT74566A (en) 1997-01-28

Similar Documents

Publication Publication Date Title
NO942899D0 (fr)
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
AU2724492A (en) Antibodies in immunosuppression
EP0801951A3 (fr) Applications d'IL-4 et/ou IL-10 et leurs anticorps
CA2075060A1 (fr) Essences pour vehicules et leur utilisation dans des preparations medicales
EP0599532A3 (fr) Compositions réticulables monocomposantes d'organosiloxane.
AU7636794A (en) Compositions including 1,1,1,2,3,4,4,5,5,5-decafluoropentane
AU7528894A (en) Hydrazino-type n2s2 chelators
AU4257193A (en) Turbo compounder
AU1378395A (en) Metal chelators
AU631681B2 (en) Radiolabeled anticoagulant peptides
EP0683676A4 (fr) Biodistribution dirigee des petites molecules.
TW257750B (fr)
EP0624621A3 (fr) Mélange à base de PC/ABS renforcée.
AU4863990A (en) Mutants of human antithrombin iii
HK1006413A1 (en) Inclusion compounds of nimesulide with cyclodextrins
ZA953700B (en) Novel sulfenamide accelerators and rubber compositions containing the same
ZA945708B (en) Rye-flour
FR2705907B1 (fr) Perfectionnements apportés aux poupées.
EP0632580A3 (fr) Etage de sortie amplificateur.
CA2171728A1 (fr) Derives de triarylethylene pour utilisation therapeutique
GR3007486T3 (fr)
EP0658625A3 (fr) Protéine susceptible d'être biotinylée utilisable pour la détermination du stade de germination d'une semence.
TW265353B (en) A dye composition
EP0638559A4 (fr) Derive de pyrazine.